Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Minako Maruyama"'
Autor:
Eriko Kawamura, Minako Maruyama, Jiro Abe, Akira Sudo, Atsuhito Takeda, Shingo Takada, Takashi Yokota, Shintaro Kinugawa, Hideyoshi Harashima, Yuma Yamada
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 20, Iss , Pp 687-698 (2020)
Here, we report on validating a mitochondrial gene therapy by delivering nucleic acids to mitochondria of diseased cells by a MITO-Porter, a liposome-based carrier for mitochondrial delivery. We used cells derived from a patient with a mitochondrial
Externí odkaz:
https://doaj.org/article/cc64909ad8ef4925ab1babd22e0632a6
Publikováno v:
Expert opinion on biological therapy. 22(9)
After the emergence of lipid nanoparticles (LNP) containing therapeutic mRNA as vaccines for use against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the clinical usefulness of nucleic acid-encapsulated LNPs is now a fact. In add
Autor:
Takashi Yokota, Akira Sudo, Minako Maruyama, Jiro Abe, Eriko Kawamura, Hideyoshi Harashima, Shingo Takada, Yuma Yamada, Shintaro Kinugawa, Atsuhito Takeda
Publikováno v:
Molecular Therapy. Nucleic Acids
Molecular Therapy: Nucleic Acids, Vol 20, Iss, Pp 687-698 (2020)
Molecular Therapy: Nucleic Acids, Vol 20, Iss, Pp 687-698 (2020)
Here, we report on validating a mitochondrial gene therapy by delivering nucleic acids to mitochondria of diseased cells by a MITO-Porter, a liposome-based carrier for mitochondrial delivery. We used cells derived from a patient with a mitochondrial
Development of a nanoparticle that releases nucleic acids in response to a mitochondrial environment
Publikováno v:
Mitochondrion. 52:67-74
The delivery of nucleic acids targeting mutant mtDNA represent a potential strategy for addressing a variety of mitochondria-related diseases. We previously developed a MITO-Porter, a nano carrier that is capable of delivering nanoparticles of nuclei
Autor:
Shin-ichiro Kitajiri, Minako Maruyama, Tomoko Kita, Hideyoshi Harashima, Yuma Yamada, Shin-ichi Usami
Publikováno v:
Mitochondrion. 55
We report on validating a mitochondrial gene therapeutic strategy using fibroblasts derived from patients with an A1555G point mutation in mitochondrial DNA coding 12S ribosomal RNA (rRNA (12S)). Wild-type rRNA (12S) as a therapeutic RNA was encapsul
Autor:
Minako Maruyama, Hajime Kitagaki, Rika Yoshida, Yoshikazu Takinami, Shinji Ando, Tomonori Nakamura, Mitsunari Maruyama, Megumi Nakamura, Yukihisa Tamaki, Takeshi Yoshizako
Publikováno v:
Clinical Imaging. 48:127-130
Systemic air emboli occur as a rare complication of percutaneous needle biopsy of the lung and video-assisted thoracoscopic surgery (VATS) marking. Here we present four cases of systemic air emboli from single institution and the imaging findings and
Autor:
Minako Maruyama, Hajime Kitagaki, Hiroshi Mori, Noriyoshi Ishikawa, Yukihisa Tamaki, Rika Yoshida, Takeshi Yoshizako
Publikováno v:
Abdominal Radiology. 42:2297-2304
This retrospective study aimed to assess the value of adding diffusion-weighted magnetic resonance imaging (DWI) or gadolinium-enhanced fat-suppressed T1WI (CEI) to T2-weighted imaging (T2WI) for preoperative T categorization in renal pelvic carcinom
Autor:
Yoshihide Shimojo, Hajime Kitagaki, Yoshikazu Takinami, Yukihisa Tamaki, Takeshi Yoshizako, Rika Yoshida, Minako Maruyama
Publikováno v:
Acta radiologica (Stockholm, Sweden : 1987). 60(4)
Background Spontaneous superior mesenteric artery (SMA) dissection is rare cause of acute abdomen. Time-dependent change of SMA dissection has not been established. Purpose To determine Sakamoto classification (SC) type of acute and chronic SMA disse
Autor:
Minako Maruyama, Takeshi Yoshizako, Rika Yoshida, Satoru Kyo, Noriyoshi Ishikawa, Hajime Kitagaki
Publikováno v:
Magnetic Resonance in Medical Sciences
Autor:
Hironori Imano, Choy-Lye Chei, Kazumasa Yamagishi, Masahiko Kiyama, Minako Maruyama, Ai Ikeda, Takashi Asada, Akihiko Kitamura, Hiroyuki Noda, Hiroyasu Iso, Renzhe Cui
Publikováno v:
Atherosclerosis. 236:438-443
Objective Studies have shown that elevated high-sensitivity C-reactive protein (hs-CRP) predicts stroke, which is a risk factor for dementia. It remains, however, unclear whether hs-CRP increases risk of dementia. Methods A prospective nested case–